1. Wenker, H., Schirmer, M. : Aktuelle Probleme in der Psychiatrie, Neurologie/Neurochirurgie (Band 8 (Lumbaler Bandscheibenvorfall und Lumboischialgie)). Hans-Huber-Verlag, Bern, Stuttgart, Wien 1979: 12-24, 42 ff.
2. Grubel, G., Schröder, F.: Gehirn, Rückenmark, periphere Nerven aus: Chirurgie Lehrbuch,. Hrsg.
Schumpelik V., Bleese N.M., Mommsen U., Enke-Verlag Stuttgart, New York 2000: 531-534 3. Niethard, F.U., Pfeil, J.: Orthopädie. Hippokrates-Verlag, Stuttgart 1992: S.366 ff.
4. Brandt M.: Die klassische Nukleotomie aus: Der lumbale Bandscheibenvorfall, Hrsg.
Breitenfelder, J., Haaker, R., Steinkopff-Verlag, Darmstadt 2003: 63-70 5. AWMF online, Bandscheibenbedingte Ischialgie. 2002
6. Schulitz, K.-P., Abel, R., Schöppe, K., Assheuer, J.: Der Bandscheibenvorfall. Deutsches Ärzteblatt 1999 (9): 548-552
7. Takahashi, H., Suguro, T., Okazima, Y., Motegi, M., Okada, Y., Kakiuchi, T.: Inflammatory cytokines in the herniated disc of the lumbar spine. Spine 1996 (21): 218-224
8. Oosterlink, W., Philip, .NH., Charing, C.: A double blind single dose comparison of intramuscular keterolac, trometamine and pethidine in the treatment of renal colic. J Clin Pharmacol Ther 1990 (30): 336-341
9. Dahl, J.B., Kehlet, H.: Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991 (66): 703-712
10. Engl, C., Lund, B., Kristensen, S.S., Axel, G., Nielsen, J.B.: Indomethacin as an adjacent after hysterektomie. Acta Anaesthesiol Scand 1989 (33): 489-501
11. Dahl, V., Raeder, J.C., Drosdal, S., Wathne, O., Brynhildsrud, J.: Prophylactic oral ibuprofen-codeine versus placebo for postoperative pain after primary hip arthroplasty. Acta Anaestesiol Scand 1995 (39): 323-326
12. Dahl, V., Raeder, J.C.: Non-opioid postoperative analgesia. Acta Anaestesiol Scand 2000 (44, Review Article): 1191-1203
13. Lee, S., Simon, M.D.: Role and regulation of Cyclooxygenase-2 during inflammation. Am J Med 1999 (106- 5B): 37-42
14. Crofford, L.J.: COX-1 and COX-2 Tissue expression: implications and predictions. J Rheumatol 1997 (24-suppl. 49): 15-19
15. O´Banion, M.K., Sadowski, H.B., Winn, V., Young, D.A.: A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes cyclooxygenas-related protein. J Biol Chem 1991 (266): 23261-23267 16. Hawkey, C.J.: COX-2-Hemmer. Lancet 1999 (353): 307-14
17. Vane, J.R.: Introduction: mechanism of action of NSAIDS. Br J Rheumatol 1996 (35- suppl. 1):
1-3
18. Dionne, R.A., Khan, A.A., Gordon, S.M.: Analgesia and COX-2 inhibition. Clin Exp Rheumatol 2001 (19-suppl. 25): 63-70
19. Romsing, J., Moinicke, S., Ostergaard D, Dahl, J.B.: Local infiltration with NSAIDs for postoperative analgesia: evidence for a peripheral analgesic action. Acta Anaestesiol. Scand.
2000 (44-6): 672-683
20. Dionne, R., Cooper, S.A.: Evaluation of preoperative ibuprofen on postoperative pain after impaction surgery. Oral Surg Oral Med Oral Pathol 1978 (45-6): 851-856
21. Dionne, R.A., Campbell, R.L., Cooper, S.A., Hall, D.L., Buckingham, B.: Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen and acetaminophen plus codeine. J Clin pharmacol 1983 (23): 37-43
22. Cashman, J., McAnulty, G.: Nonsteroidal Anti-Inflammatory Drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. Drugs 1995 (49- 1): 51-70 23. Lefkowith, J.B.: Cyclooxygenase-2-Specificity and its clinical implications. Am J Med. 1999
(106 -5B): 43-50
24. Gray, D.A., Langrieger, N., Reschmaier, J. et al.: The effect of acetylsalicylic acid on renal function in the Pekin duck. Br J Pharmacol 1984 (82): 329-38
25. Vane, J.R., Flower, R.J., Botting, R.M., editors.: Aspirin and other salicylates. London: Chapman
& Hall Medical, 1992: 510-531
26. Bevis, P.J.R., Bird, H.A., Lapham, G.: An open study to assess the safety and tolerability of Meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Br J of Rheumatol 1996 (35 -suppl. 1): 56-60
27. Clive, D.M., Stoff, J.S.: Medical progress. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New Engl J Med 1984 (310-9): 563-572
28. Stichtenoth, D.O., Frölich, J.C.: The second generation of COX-2 inhibitors. What advantages do the newest offer? Drugs 2003 (63-1): 33-45
29. Hochberg, M.C.: What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist`s perspective. Clin Exp Rheumatol 2001 (19- suppl.25): 15-22 30. Stichtenoth, D.O., Frölich, J.C.: COX-2 and the kidneys. CurrPharm Des 2000 (6): 1737-1753 31. Galli, G.: Do non-steroidal-anti-inflammatory drugs and COX-2 selective inhibitors have different
renal effects? J Nephrol 2002 (Review-15): 480-488
32. Appel, G.B.: Cox-2 inhibitors and the kidney. Clin Exp Rheumatol 2001 (19-suppl 25) 37-40 33. Goodman, S., Ma, T., Trindade, M., Ikenoue, T., Matsuura, I., Wong, N.; Fox, N., Genovese, M.,
Regula, D., Smith, R.: Cox-2-selective NSAID decreases bone ingrowth in vivo. J Orthop Res.
2002 (20 -6): 1164-1169
34. Long, J., Lewis, S., Kuklo, T., Zhu, Y., Riew, K.D.: The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am. 2002 (84-A -10): 1763-1768
35. Stichenoth, D.O., Zeidler, H., Frölich, J.C.: Neue nichtsteroidale Antirheumatika: Selektive Hemmstoffe der induzierbaren Cyclooxygenase. Med Klein 1998 (93): 407-415
36. Fachinformation Firma Pfizer 2000
37. Hubbard, R.C., Mehlisch, D.R..: SC-58635, a highly selective inhibitor of Cox-2, is an effective analgesic in an acute post surgical pain model. J Invest Med 1996 (44): 293A
38. Mehlisch, D.R., Hubbard, R.C.: Analgesic efficacy and plasma levels of a highly selective inhibitor of COX-2 (SC-58635; SC) in patients with postsurgical dental pain. Clin Pharmacol Ther 1997 (61): 195
39. Geis, G.S.: Update of clinical developments with Celecoxib, a new specific Cox-2 inhibitor: What can we expect? J Rheumatol 1999 (26- Suppl. 56): 31-36
40. Buvanendran, A., Kroin, J.S., Tuman, K.J., Lubenow, T.R., Elmofty, D., Moric, M., Rosenberg, A.G.: Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement. A randomized controlled trial.
JAMA 2003 (290): 2411-2418
41. Bekker, A., Cooper, P.R., Frempong-Boadu, A., Babu, R., Errico, T., Lebovits, A.: Evaluation of preoperative administration of the cyclooxygenese-2 inhibitor Rofecoxib for the treatment of postoperative pain after lumbar disc surgery. Neurosurgery 2002 (50-5): 1053-1058
42. Reuben, S.S., Connelly, N.R.: Postoperative analgesic effects of Celecoxib or Rofecoxib after spinal fusion surgery. Anesth Analg 2000 (91):1221-1225
43. Buttgereit, F.: Wirkungsmechanismen und Wirkungen der Glucocorticoide. Z Rheumatol. 2001 (60): 117-119
44. Baxendale, B.R., Vater, M., Lavery, K.M.: Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia 1993 (48): 961-964
45. Naylor, A., Fowers, M.W., Bramley, J.E.D.: The value of dexamethasone in the postoperative treatment of lumbar disc prolapse. OrthopClin North Am 1977 (8-1): 3-8
46. Watters, W.C. III, Temple, A.P., Granberry, M.: The use of dexamethasone in primary lumbar disc surgery. A prospective, randomized, double-blind study. Spine 1989 (14 – 4): 440-442 47. Glasser, R.S., Knego, R.S., Delashaw, J.B., Fessler, R.G.: The perioperativ use of corticosteroids
and bupivacaine in the management of lumbar disc disease. J Neurosurg 1993 (78): 383-387 48. McPhee, I.B., Williams, R.P., Swanson, C.E.: Factors including wound healing after surgery for
metastatic disease of the spine. Spine 1998 (23 – 6): 726-733
49. Vane, J.R., Botting, R.M.: Review: New insights into the mode of action of antiinflammatory drugs. Inflamm Res 1995 (44): 1-10
50. Kissin, I.: Preemptive Analgesia. Anesthesiology 2000 (93): 1138-43
51. Kelly, D.J., Ahmad, M., Brull, S.J.: Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anesth 2001 (48-10): 1000-1010
52. Furst, D.E., Manning, D.C.: Future directions in pain management. Clin Exp Rheumatol 2001 (19 -Suppl. 25): 71-76
53. Woolf, C.J., Salter, M.W.: Neuronal plasticity: Increasing the gain in pain. Science 2000 (288):
1765-1768
54. Woolf, C.J., Wall, P.D.: Morphine-sensitive and morphine-intensive actions of c-fibre input on the rat spinal cord. Neuroscience Lett 1986 (64): 221-225
55. Woolf, C.J., Chong, M.S.: Preemptive analgesia-treating postoperative pain by preventing the establishment of central sentization. Anesth Analg 1993; (77-2): 362-379
56. Wilkinson, H.A.: The failed back syndrome. New York: Harper & Row, 1983.
57. Dvorak, J.: The outcome of surgery for lumbar disc herniation. I: A 14-17 years`follow-up with emphasis on somatic aspects. Spine 1988 (13): 1418-1422
58. Naylor, A.: The late results of laminectomy for lumbar disc prolapse. J Bone Joint Surg 1974 (56-B): 17-29
59. Hasenbring, M., Marienfeld, G., Kuhlendahl, D., Soyka, D.: Risk factors of chronicity in lumbar disc patients. A prospective investigation of biologic, psychologic, and social predictors of therapy outcome. Spine 1994 (19) : 2765-2795
60. Pedersen, J.L., Kehlet, H.: Hyperalgesia in human model of acute inflammatory pain:
methodological study. Pain 1998 (74 -2-3): 139-151
61. Holthusen, H., Irsfeld, S., Lipfert, P.: Effect of pre-or post-traumatically applied i.v. lidocaine on primary and secondary hyperalgesia after experimental heat trauma in humans. Pain 2000 (88-3):
295-302
62. Ilkjaer, S,, Nikolajsen, L., Hansen, T.M., Wernberg, M., Brennum, J., Dahl, J.B.: Effect of i.v.
ketamine in combination with epidural bupivacaine or epidural morphine on postoperative pain and wound tenderness after renal surgery. Br J Anaesth. 1998 (81-5): 707-712
63. Schwetlick, G.: Mikrochirurgische lumbale Bandscheibenoperation. Orthopäde (1998) (27):
457-465
64. Griffith, H.B., Mathew, B.G.: Microdiscectomy. Br J Med. 1990 (44-6): 410-412 65. Wilkinson, H.A.: The failed back syndrome. Harper & Rowe, New York 1983.
66. Novy, D.M., Nelson, D.V., Berry, L.A., Averill P.M.: What does the Beck Depression Inventory measure in chronic pain? A reappraisal. Pain 1995 (61): 261-70
67. Hautzinger, M., Bailer, M., Worall, H., Keller, F.: BDI, Beck-Depressions-Inventar in Testhandbuch, 2, überarbeitete Auflage, Verlag Hans Huber 1995
68. Hautzinger, M., Bailer, M.: ADS. Allgemeine Depressions Skala. Beltz Test 1992
69. Flor, H., Rudy, T.E., Birbaumer, N., Streit, B., Schugens, M.M.: Zur Anwendbarkeit des West Haven-Yale Multidimensional Pain Inventory im deutschen Sprachraum. Daten zur Realibilität und Validität des MPI-D. Schmerz 1990 (4): 82-87
70. Kerns, R.D., Turk, D.C., Rudy, T.E.: The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985 (23): 345-356
71. Atkinson, J.H., Slater, M.A., Williams, R.A., Zisook, S., Patterson, T.L., Grant, I., Wahlgren, D.R., Abramson, I., Garfin, S.R.: A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998 (76-3): 287-296
72. Backonja, M., Beydoun, A., Edwards, K.R., Schwartz, S.L., Fonseca, V., Hes, M., LaMoreaux, L., Garofalo, E.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998 (280-21): 1831-1836
73. Bodian, C.A., Freedman, G., Hossain, S., Eisenkraft, J.B., Yaakov.: The Visual Analog Scale for pain: clinical significance in postoperative patients. Anesthesiology 2001 (95-6): 1356-1361 74. Walde, B., Schafer, M., Henzi, I., Tramer, M.R.: Efficacy and safety of patient-controlled opioid
analgesia for acute postoperative pain. Acta Anesthesiologica Scandinavia 2001 (45-7): 795 ff.
75. Bernd, W., Seintsch, H., Amstad, R., Burri, G., Weber, V.: Organisationsmodell der postoperativen Schmerztherapie am Beispiel eines Krankenhauses der Regelversorgung. Der Anaesthesist 2004: Onelinepublikation
76. Clark, P., Lavielle, P., Martinez, H.: Learning from pain scales : patient perspective. J Rheumatol 2003 (30-7) : 1584-1588
77. Guidelines on the use of NSAIDs in the perioperative period. London: Royal College of Anaesthesists 1998.
78. LeRoux, P.D., Samudrala, S.: Postoperative pain after lumbar disc surgery: a comparison between parenteral keterolac and narcotics. Acta Neurochirug (Wien) 1999 (141): 261-267 79. Papavero, L., Caspar, W.: The lumbar microdiscectomy. Acta Orthop. Scand. 1993 (Suppl.-251):
34-37
80. Lipsky, P.E.: The clinical potential of Cyclooxygenase-2-spezific inhibitors. J Med 1999 (106-5B):
51-57
81. Merk, H., Krämer, R., Baltzer, W.A., Liebau, C.: Mikrochirurgische lumbale Bandscheibenoperation. Technik und Komplikationen. Orthopäde 1999 (28): 593-597
82. Schirmer: Neurochirurgie. Urban & Schwarzenberg-Verlag, 9. Auflage 1998: 134-136, 347 83. Melzack R., Wall P.D.: Textbook of pain , Elsevier-Verlag, Edingburgh, Churchhill & Livingstone
1999.
84. Filippi, R., Laun, J., Jage, J., Perneczky, A.: Postoperative pain therapy after lumbar disc surgery.
Acta Neurochir (Wien) 1999 (141): 613-618
85. American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section.
Practice guidelines for acute pain management in the perioperative setting: A report by the American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section.
Anesthesiology 1995 (82): 1071-1081
86. Gillies, G.W.A., Kenny, G.N.C., Bullingham, R.E.S., McArdle, C.S.: The morphine sparing effect of keterolac tromethamine: a study of a new non-steroidal anti-inflammatory agent after abdominal surgery. Anesthesia 1987 (42): 727-731
87. Catapano, M.S.: The analgesic efficiacy of keterolac for acute pain. J Emerg Med 1996 (14):
67-75
88. Strom, B.L., Berlin, J.A., Kinman, M.A., Spitz, P., Hennessy, S., Feldmann, H., Kimmel, S., Carson, J.: Parenteral keterolac and risk of gastrointestinal and operative side bleeding: a postmarketing surveillance study. JAMA 1996 (275): 376-382
89. Smith, K., Halliwell, R.M.T., Lawrence, S., Klineberg, P.L., O´Connell, P.: Acute renal failure associated with intramuscular keterolac. Anaesth Intensive Care 1993 (21): 700-703
90. Lewis, S.: Keterolac in Europe [letter]. Lancet 1994 (343): 784
91. Davies, N.M., Jamali, F.: COX-2 selective inhibitors cardic toxicity: getting to the heart of the matter. J Pharm Pharmaceut Sci 2004 (7-3): 332-336
92. Day, R., Morrison, B., Luza, A., Castaneda, O., Strusberg, A., Nahir, M., Helgetveit, K.B., Kress, B., Daniels, B., Bolognese, J., Kurpa, D., Deidenberg, B., Ehrich, E.: A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Arch Intern Med 2000 (160-12): 1781-1787
93. Ray, W.A., Stein, C.M., Daugherty, J.R., Hall, K., Arbogast, P.G., Griffin, M.R.: COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. The Lancet 2002 (Research Letters-360): 1071-1073
94. Huang, J.J., Tguchi, A., Hsu, H., Andriole, G.L. Jr, Kurz, A.: Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: a prospective, randomized, double-blind, placebo-controlled trial. J Clin Anesth 2001 (14): 94-97 95. Malstrom, K., Daniels, S., Kotey, P.: Comparison of rofecoxib and celecoxib, two
cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther 1999 (21): 1653-1663
96. Hawkey, C.J.: NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials? The gastroenterologist’s perspective. Clin Exp Rheumatol 2001 (19-Suppl.25): 23-30
97. Abramson, S.B., Furst, D.E., Hochberg, M.C., Patrono, C.: Controversies in COX-2 Inhibitor therapy: Closing remarks. Clin Exp Rheumatol 2001 (19-Suppl. 25): 77-80
98. Davies, N.M., McLachlan, A.J., Day, R.O., Williams, A.M.: Clinical pharmacokinetics and Pharmacodynamics of celecoxib: a selective cyclooxygenase-2 inhibitor. Clin Pharmacokinet 2000 (38): 225-242
99. Davies, N.M., Teng, X.W., Skjodt, N.M.: Pharmacokinetics of rofecoxib: a specific.Cyclooxygenase-2 inhibitor. Clin Pharmacokinet 2003 (42): 545-556
100. Walter, M.F., Jacob, R.F., Day, C.A., Dahlborg, R., Weng, Y., Mason, P.: Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification
comparison to sulfinamide COX-2 inhibitors and NSAIDs. Atherosclerosis 2004 (177- 2):
235-243
101. Whelton, A., Fort, J.G., Puma, J.A., Normandin, D., Bello, A.E., Verburg, K.M.:
Cyclooxygenase-2 spezific inhibitors and cardiorenal function: a randomised, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001 (8-2):
85-95
102. Chiolero, A., Maillard, M.P., Burnier, M.: Cardiovascular hazard of selective COX-2 inhibitors: myth or reality? Expert Opin Drug Saf 2002 1 (1): 45-52
103. Garret A, FitzGerald MD. Coxibs and cardiovsaular disease. New Engl J Med 2004 (351):
1709-1711
104. Scheen, A.J.: Withdrawal of Rofecoxib (Vioxx): what about cardiovascular safety of COX-2 selective non-steroidal anti-inflammatory drugs? Rev Med Liege. 2004 (59-10): 565-569
105. Solomon, D.H., Schneeweiss, S., Glynn, R.J., Levin, R., Avorn, J.: Relationship between selective Cyclooxygenase-2-Inhibitors and acute Myocardial infarction in older adults. Clinical Investigation and Report 2004 (109): 2068-2073.
106. Geissner, E.: Psychologische Modelle des Schmerzes und der Schmerzverarbeitung.
Weinheim-Verlag 1992: 25-41
107. Schumacher, J.: Psychologie des Akutschmerzes: Emotionale, kognitive und soziale Faktoren postoperativer Schmerzen. in Psychologie des Schmerzes, Diagnose und Therapie, Hrsg.
Geissner, E., Jurgnitsch, G., Psychologie-Verlag Union 1992: 189-202
108. Haythornthwaite, J.A., Sieber, W.J., Kerns, R.D.: Depression and the chronic pain experience.
Pain 1991 (46): 177-184
109. Keefe, F.J., Wilkins, R.H., Cook, A., Crisson, J.E., Muhlbaier, L.H.: Depression, pain, and pain behavior. Journal of Consulting and Clinical Psychology 1986 (54): 665-669.
110. Kohlmann, T., Nuding, B., Raspe, H.H.: Funktionsbehinderung, schmerzbezogene und emotionale Beeinträchtigung bei Rückenschmerzen in Psychologie des Schmerzes, Diagnose und Therapie, Hrsg. Geissner, E., Jurgnitsch, G., Psychologie-Verlag Union 1992:.107-121 111. King, J.S.: Dexamethasone- a helpful adjunct in management after lumbar discetomy.
Neurosurgery 1984 (14): 697-700.
112. Saal, J.S., Franson, F.C., Dobrow, R., Saal. J.A., White, A.H., Goldthwaite, N.: High Levels of inflammatory phosphoplipase A2 activity in lumbar disc herniations. Spine 1990 (15):
674-678.
113. Maroon, J.C., Abla, A., Jeffrey, Bost.: Association between peridural scar and persistent low back pain after lumbar discectomy. Neurological Research 1999 (21- Suppl.1): 43-46
114. BenDebba, M., Alphen van, H.A., Long, D.M.: Association between peridural scar and activity-related pain after lumbar discectomy. Neurological Research 1999 (21- Suppl.1): 37-42 115. Lowell, T.D., Errico, T.J., Eskenazi, M.S.: Use of epidural steroids after discectomy may
predispose to infection. Spine 2000 (25): 516-519.
116. King, J.S.: Dexamethasone- a helpfull adjunct in mangement after lumbar discectomy.
Neurosurgery 1984 (14): 697-700.
117. Lukas A, Petersen G, Hecker H, Ensink M, Lüdemann W, Karst M, Adams HA. Die preemptive Wirkung von (S)-Ketamin auf postoperative Schmerzen nach Bandscheiben-Operationen.
Schmerz 2001 (15- Suppl. 1): 75-76